James Nisco
Fortuna: 37 573 $ al 31/05/2026
Fortuna: 37 573 $ al 31/05/2026
James Nisco currently works at Lisata Therapeutics, Inc., as Chief Accounting Officer, SVP-Finance & Treasury from 2024.
Mr. Nisco also formerly worked at Caladrius Biosciences, Inc., as Vice President-Finance & Treasury.
Mr. Nisco received his undergraduate degree from State University of New York College at Oneonta and Masters Business Admin degree from Pace University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 09/01/2026 | 11.561 ( 0,13 % ) | 37 573 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| LISATA THERAPEUTICS, INC. | Director Financiero/CFO | 01/08/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 4 |
|---|---|
State University of New York College at Oneonta
State University of New York College at Oneonta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pace University
Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Health Technology |
Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.